Paclitaxel causes degeneration of both central and peripheral axon branches of dorsal root ganglia in mice

[1]  Wenqin Luo,et al.  Modality-Based Organization of Ascending Somatosensory Axons in the Direct Dorsal Column Pathway , 2013, The Journal of Neuroscience.

[2]  Joong Hee Kim,et al.  Diffusion tensor imaging of the mouse brainstem and cervical spinal cord , 2013, Nature Protocols.

[3]  Jean-Pierre Julien,et al.  Axonal transport deficits and neurodegenerative diseases , 2013, Nature Reviews Neuroscience.

[4]  M. Farah.  BACE1 influences debris clearance and axonal regeneration in injured peripheral nerve , 2012, Journal of the peripheral nervous system : JPNS.

[5]  Guido Cavaletti,et al.  Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. , 2012, Critical reviews in oncology/hematology.

[6]  G. Cavaletti,et al.  Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice. , 2011, Cancer research.

[7]  D. Price,et al.  Reduced BACE1 Activity Enhances Clearance of Myelin Debris and Regeneration of Axons in the Injured Peripheral Nervous System , 2011, The Journal of Neuroscience.

[8]  G. Cavaletti,et al.  Chemotherapy-induced peripheral neurotoxicity , 2010, Nature Reviews Neurology.

[9]  J. Griffin,et al.  Measuring nerve regeneration in the mouse , 2010, Experimental Neurology.

[10]  G. Cavaletti,et al.  Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools. , 2010, European journal of cancer.

[11]  M. Tomonaga,et al.  Dorsal Column Degeneration after Bortezomib Therapy in a Patient with Multiple Myeloma , 2009, Case Reports in Oncology.

[12]  C. Loprinzi,et al.  Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. , 2008, European journal of cancer.

[13]  M. Stillman,et al.  Chemotherapy-induced peripheral neuropathy. , 2005, Oncology nursing forum.

[14]  P. Mantyh,et al.  An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat , 2007, Brain Research.

[15]  G. Y. Wong,et al.  Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells , 2007, Experimental Neurology.

[16]  A. Höke,et al.  Erythropoietin protects sensory axons against paclitaxel-induced distal degeneration , 2006, Neurobiology of Disease.

[17]  Fred H. Gage,et al.  Therapeutic interventions after spinal cord injury , 2006, Nature Reviews Neuroscience.

[18]  Gary J. Bennett,et al.  Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction , 2006, Pain.

[19]  J. Glass,et al.  Wlds mice are resistant to paclitaxel (taxol) neuropathy , 2002, Annals of neurology.

[20]  J. Griffin,et al.  Delayed Macrophage Responses and Myelin Clearance during Wallerian Degeneration in the Central Nervous System: The Dorsal Radiculotomy Model , 1994, Experimental Neurology.

[21]  J. Griffin,et al.  Macrophage Systems in Peripheral Nerves. A Review , 1993, Journal of neuropathology and experimental neurology.

[22]  Alex Sparreboom,et al.  Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes. , 2006, European journal of cancer.

[23]  K. Kuroi,et al.  Neurotoxicity of taxanes: Symptoms and quality of life assessment , 2004, Breast cancer.

[24]  D. Simmons,et al.  Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. , 1993, Blood.